Skip to content

Clinical trials

Asperger Syndrome trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asperger Syndrome Phase: Not applicable Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20071
20083
20093
20103
20112
20121
20134
20141
20151
20181
20201
20212
20221
20233
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting4
Unknown status4
Terminated2
Active, not recruiting1
Withdrawn1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of South Florida4
Yale University3
Children's Hospital Medical Center, Cincinnati2
University of Pennsylvania2
University of Pittsburgh2
Aberystwyth University1
Bayside Health1
CogCubed, Corp1
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.1
Icahn School of Medicine at Mount Sinai1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asperger Syndrome33
Autistic Disorder27
Autism Spectrum Disorder22
Child Development Disorders, Pervasive13
Anxiety Disorders5
Anxiety, Separation4
Generalized Anxiety Disorder4
Obsessive-Compulsive Disorder4
Phobia, Social4
Attention Deficit Disorder with Hyperactivity3

Trials

Showing 76 to 33 of 33. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.